COVID-19 pandemic
Moderna announces that they will begin testing their vaccine candidate, mRNA-1273, on adolescents aged 12–17 years.
Sources: CNBC
Changes
- Moderna announces that they will begin a study by testing their vaccine candidate on adolescents aged 12 to less than 18.
- Moderna announces that they will begin a study by testing mRNA-1273, their vaccine candidate, on adolescents (ages 12–17 years old).
- Moderna announces that they will begin a testing their vaccine candidate, mRNA-1273, on adolescents aged 12–17 years.
- Moderna announces that they will begin testing their vaccine candidate, mRNA-1273, on adolescents aged 12–17 years.